您要查找的是不是：
- major urinary protein 嚴重的尿蛋白, 較多的尿蛋白
- Objective To distinguish the sources of the proteinuria by analyzing the compositions of the urinary protein. 目的分析尿蛋白成分來(lái)鑒別蛋白尿來(lái)源。
- Results: Fenugreek treatment decreased urinary protein excretion,serum creatinine and blood urea nitrogen in dia... 結果:胡蘆巴能減少尿蛋白排泄率,降低血肌酐和尿素氮水平,減輕腎臟病變程度。
- There was no correlation between artery blood pressure and RCBF or urinary protein. 平均動(dòng)脈壓在整個(gè)病程中與腎皮質(zhì)血流無(wú)顯著(zhù)相關(guān)。
- Conclusion: Elastase is an ideal drug in treating urinary protein in patients... 結論:彈性酶是治療糖尿病腎病蛋白尿的理想藥物。
- Objective: To investigate the effects of elastase on urinary protein in diabetic nephropathy. 目的:探討彈性酶對糖尿病腎病的治療作用。
- The relation between expressions of ED_1 and MCP-1 was positieelycorrelated with 24-hour urinary protein and creatinine clear rate. 相關(guān)分析顯示: MCP-1、 ED_1平均光密度值與 24 小時(shí)尿微量白蛋白、血清肌酐清除率具有顯著(zhù)直線(xiàn)正相關(guān), MCP-1 與 ED_1平均光密度值二者間也具有正相關(guān)。
- The BG,Bp,BUN,Cr and urinary protein excretion rate of 21 NIDDM patients with proteinuria,who were treated for 2 weeks with captopril,were studied. 觀(guān)察21例伴有蛋白尿的非胰島素依賴(lài)型糖尿?。∟IDDM）患者用卡托普利（Captopril）治療2周前后的尿蛋白排泄率，血糖、血壓、血尿素氮（BUN）、血肌酐（Cr）等的變化。
- The levels of blood lipid,blood viscosity,blood creatinine (Cr),blood urea nitrogen(BUN) and urinary protein were detected before and after treatment. 治療前后檢測血脂、血粘度、血肌酐（Cr）、血尿素氮（BUN）及尿蛋白。
- Urinary protein was significantly reduced in T75 after 2 wk of treatment and was also declined in the other two treatment groups but only after 2 mo. 2周后在T75治療組尿蛋白顯著(zhù)降低，僅在2月后，其他兩個(gè)治療組的尿蛋白降低。
- Results: After treatment, the clinical symptoms, urinary protein and immunity improved;the Prednisonum used was lessened obviously. 結果:治療后患者臨床癥狀、蛋白尿、免疫功能有明顯改善,強的松用量顯著(zhù)減少。
- Results: MMF could decrease urinary protein, improve renal function and hematuria, therapeutic efficacy were significantly (P<0.05). 結果：霉酚酸酯能降低尿蛋白，減輕血尿，改善腎功。
- Urinary podocyte excretion level in IgAN patients is correlated with 24 h urinary protein excretion and specific pathological damages. 足細胞尿排泄的水平與蛋白尿水平呈正相關(guān)，與腎臟病理類(lèi)型也有一定的關(guān)系。
- Results: At 8th week, kidney weight/body weight (KW/BW) and 24 hours urinary protein count increased significantly in DN model group, compared with control group (P<0.01, P<0.01). 結果8周時(shí)糖尿病腎病組腎重/體重比和24小時(shí)尿蛋白定量明顯增高;與對照組比較有顯著(zhù)性差異(P<0.;01;P<0
- After administration of losartan for 2 weeks and 12 weeks, 24-hour urinary protein excretion (24 hUPE), Scr and Ccr were measured, and renal morphology was observed. 分別于2周和12周殺鼠,觀(guān)察體重、腎重、腎重/體重指數、尿蛋白量(24 h)、Scr、Ccr以及腎組織病理改變;
- Before and after therapy the changes in quantitative measurement of 24 hours urinary protein,blood creatinine(Cr),complement C3,C4,and antinuclear antibody(ANA) were detected. 在治療前后檢測 2 4小時(shí)尿蛋白定量、血肌酐、C3、C4、抗核抗體 (ANA )的變化。
- The analysis can be performed by examining serum or urinary proteins by immunoelectrophoresis. 可用免疫電泳方法進(jìn)行血清或尿中蛋白的分析。
- Blood examination showed leukocytosis, thrombocytopenia, and positive urinary protein, hematuria, urine inside membrane-like manifestations such as renal dysfunction. 血常規檢查可見(jiàn)白細胞增多、血小板下降，并有尿蛋白陽(yáng)性、血尿、尿內出現膜狀物等腎功能損害表現。
- The change of recur degree , urinary protein, serum albumin, cholesterol , T cell subpopulation , croticosteroid before and after treatment were observed. 觀(guān)察治療前后復發(fā)次數及尿蛋白、血清白蛋白、膽固醇、T細胞亞群、血清皮質(zhì)醇的變化。
- The original antihyperglycemic therapies were identical.Results: Urinary protein in the treatment group decreased obviously.These changes were not observed in the control group. 結果:彈性酶組糖尿病腎病患者的尿蛋白明顯減少,而安慰劑組則無(wú)明顯改變。
